BackApexigen- Warrants (29/07/2027) Overview

Apexigen- Warrants (29/07/2027) Current Cash

Apexigen- Warrants (29/07/2027)'s current cash is $9.4M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.37M
↓ 87.83% YoYΔ $-67.60M vs prior year quarter

Peer average

Loading

Apexigen- Warrants (29/07/2027) Current Cash History

Loading

Apexigen- Warrants (29/07/2027) vs. peers: Current Cash Comparison

Loading

Apexigen- Warrants (29/07/2027) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apexigen- Warrants (29/07/2027) (APGNW) FAQ

Apexigen- Warrants (29/07/2027) (APGNW) currently reports a current cash of $9.4M as of June 2023. That compares with $77M in the prior-year period — down 87.8% year over year. Use the charts on this page to explore Apexigen- Warrants (29/07/2027)'s current cash history and peer comparisons.

Apexigen- Warrants (29/07/2027)'s current cash decreased from $77M to $9.4M — a 87.8% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Apexigen- Warrants (29/07/2027) reported $9.4M in current cash as of June 2023. That compares with $77M in the prior-year period — down 87.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $9.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apexigen- Warrants (29/07/2027), and consider following APGNW for alerts when major investors trade the stock.